Skip to main content

Advertisement

SpringerLink
Log in

The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Primary systemic therapy (PST; such as chemotherapy) has been approved as the standard therapy. Breast-conserving surgery is involved in 60–70% of breast cancer operations, and cancer can spread in the period between the initial treatment and preoperative chemotherapy. To reduce the residual tumor in persistent disease of breast tissue, determining the margin including normal tissue when removing the tumor is very difficult. With the development of the color Doppler method, contrast-enhanced ultrasonography (CEUS) allows visualization of the tumor bloodstream. The availability and efficacy of CEUS for setting the resection margin in breast-conserving surgery were examined and compared with MRI imaging as tools for making decisions for breast-conserving surgery.

Methods

One hundred seventy patients underwent breast cancer operations: 59 were PST(+) and 111 PST(−). Imaging studies, ultrasonography and MRI, to measure the size of the tumor were performed twice, before and after chemotherapy, for PST patients. This was carried out not only to measure the residual tumor size after PST, but also to detect whether pathologically complete response (pCR) had been achieved or not. Fifty-nine patients received CEUS after PST, and we determined the precision of CEUS and conventional US.

Results

The sensitivity of CEUS for pCR was 80.0% (95% CI 0.571–0.88), specificity 98.0% (95% CI 0.933–0.996), positive predictive value 88.9% (95% CI 0.635–0.978) and negative predictive value 96.0% (95% CI 0.914–0.976). The difference between the pathological examination and ultrasonography, conventional ultrasonography and CEUS was −4.455 ± 2.02 and 2.582 ± 2.298 cm (95% CI −13.11 to −0.96, p = 0.0235); CEUS was near the diameter of the actual pathological examination.

Conclusion

Contrast-enhanced ultrasonography is suitable for the preoperative examination, especially after PST, to determine the resection margin before breast-conserving surgery and detects pCR, which can help to avoid surgical procedures in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. The Guideline of Breast Cancer Therapy ① Surgical treatment for JBCS; 2007.

  2. Kaufmann M, Hortobagyi GN, Goldhirsch A, Scholl S, Makris A, Valagussa P, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol. 2006;24(12):1940–9.

    Article  PubMed  Google Scholar 

  3. van de Velde CJ. Preoperative chemotherapy in operable breast cancer. The influence of timing FEC in relation to surgery. Drugs. 1993;45 Suppl 2:31–7 (discussion 36–7).

    Google Scholar 

  4. Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N, et al. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer. 2002;95(4):681–95.

    Article  PubMed  Google Scholar 

  5. Mukai H, Watanabe T, Mitsumori M. Safety and efficacy trial of preoperative sequential chemo-radiation therapy for the nonsurgical treatment (NST)in early breast cancer (EBC): Japan Clinical Oncology Group trial (JCOG 0306). In: 44st annual meeting of the American Society of Clinical Oncology; 2008.

  6. Veronesi U, Zurrida S. Breast conservation: current results and future perspectives at the European Institute of Oncology. Int J Cancer. 2007;120(7):1381–6.

    Article  PubMed  CAS  Google Scholar 

  7. Shien T, Akashi-Tanaka S, Miyakawa K, Hojo T, Shimizu C, Seki K, Ando M, Kohno T, Taira N, Doihara H, Katsumata N, Fujiwara Y, Kinoshita T. Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer. World J Surg. 2009;33(1):44–51.

    Google Scholar 

  8. Fuminori M. Contrast-enhanced ultrasonography for the breast cancer. Tokyo: The Medical Eye; 2007.

    Google Scholar 

  9. Hlawatsch A, Teifke A. Preoperative assessment of breast cancer: sonography versus MR imaging. Am J Roentgenol. 2002;179(6):1493.

    Google Scholar 

  10. Yeh E. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. Am J Roentgenol. 2005;184(3):868.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Oncology, Gunma Prefectural Cancer Center, 617-1 Takabayashi-nishi cho, Ota, Gunma, 373-8550, Japan

    Tomomi Fujisawa, Tomoko Hirakata & Yasuhiro Yanagita

  2. Department of Pathology, Gunma Prefectural Cancer Center, Gunma, Japan

    Misa Iijima

  3. Department of Diagnostic Radiology, Gunma Prefectural Cancer Center, Gunma, Japan

    Hiroyuki Horikoshi

  4. Department of 2nd Inspection, Gunma Prefectural Cancer Center, Gunma, Japan

    Koji Takeuchi & Yumi Saitoh

Authors
  1. Tomomi Fujisawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomoko Hirakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuhiro Yanagita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Misa Iijima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroyuki Horikoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Koji Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yumi Saitoh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomomi Fujisawa.

About this article

Cite this article

Fujisawa, T., Hirakata, T., Yanagita, Y. et al. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer. Breast Cancer 20, 75–82 (2013). https://doi.org/10.1007/s12282-011-0311-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-011-0311-4

Keywords

Search

Navigation